IGI opens FY27 strong: consolidated PAT up 31% YoY to ₹166 Cr, EBITDA margin at 60%
PAT +31% YoY · revenue +23.2% · margins expanding · beat vs street
₹370.78 Cr
+23.2% YoY
₹165.74 Cr
+31% YoY
42.87%
+2.6pp YoY
₹3.84
IGI began FY27 from a position of strength. Consolidated revenue from operations rose 23.2% YoY to ₹370.78 Cr (Q1 FY26: ₹300.91 Cr) and consolidated PAT climbed 31.0% to ₹165.74 Cr (₹126.53 Cr), lifting basic EPS to ₹3.84 from ₹2.92. Management attributed the print to broad-based momentum across lab-grown diamond (LGD) loose stones, LGD jewellery and coloured gemstones. Sequentially the quarter softened — revenue was near-flat (+0.6% over Q4's ₹368.56 Cr) and PAT fell 7.7% from Q4's ₹179.60 Cr — but the March quarter is a balancing figure within the company's transitional 15-month prior year, so YoY is the meaningful lens and it reads clearly strong.
Q1 FY-2027 vs prior quarters
The margin story confirms operating leverage in this asset-light, single-segment certification model: EBITDA grew ~29% YoY to roughly ₹239.6 Cr and EBITDA margin expanded ~270bps to ~60%. Net margin on total income widened to 42.9% from 40.2% a year ago, though it sits below Q4's 46.4%. There are no exceptional items on either side, so reported and underlying growth are the same — the 31% is clean. Consolidated PAT is effectively all owners' as non-controlling interest is negligible and the ten management-certified subsidiaries carried only a ₹1.82 Cr aggregate loss.
The stock went into the print at ₹338.15, down 4% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
Management projects continued strong performance, guiding for 15% revenue growth and 20% EBITDA growth in FY27, with a focus on maintaining current margin levels. Key growth drivers include increased capacity in lab-grown diamonds and deeper penetration in natural diamonds, supported by strategic investments in brand b
— This quarter: beat
The quarter runs ahead of management's own FY27 guidance from the Q4 concall (15% revenue / 20% EBITDA growth, ~60% margin maintenance) and matches management's press-release framing verbatim — the 23% revenue / 29% EBITDA / 31% PAT claims tie out to the filing. The consolidated-vs-standalone gap is material and worth flagging: standalone (India) revenue rose 22.2% to ₹286.16 Cr but standalone PAT grew only 12.5% to ₹154.60 Cr, versus the +31% consolidated print — the difference is the international engine, with outside-India revenue up ~30% YoY to ₹95.01 Cr as the US business gains traction, Italy operations commence and the AGL colour-stone acquisition widens the addressable market. Pre-print street consensus is thin for this recently-listed name, but available broker data implied an EPS beat (est ~₹2.9 vs ₹3.84 actual). Alongside results the board scheduled the 28th AGM for Aug 14, 2026, granted 629,814 stock options under the 2024 plan, and filed its FY26 BRSR.
W1
Whether the 23% revenue / 29% EBITDA pace holds against management's 15%/20% FY27 guidance and ~60% EBITDA-margin maintenance
W2
Outside-India revenue trajectory (₹95.01 Cr, +30% YoY) as US traction builds and Italy operations ramp
W3
AGL colour-stone acquisition integration and its contribution to the coloured-gemstone certification TAM
Statement in Rs million (÷10 for ₹Cr); figures reconcile exactly to our records. No exceptional/one-off items. Prior FY is a transitional 15-month period and the 31-Mar-2026 (Q4) column is a balancing figure per note 5. Non-controlling interest negligible; ten management-certified subsidiaries posted ₹1.82 Cr aggregate after-tax loss. Standalone PAT +12.5% YoY vs consolidated +31% — divergence driven by overseas subsidiaries.
Guidance vs reality: bullish call masks -87.7% YoY revenue collapse
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Sell
confidence 3/10
Grade C
Delivered numbers match call but YoY comparison shows -87.7% revenue decline vs claimed +23% growth. Guidance of 15% FY27 growth now suspect.
Negative
next 1–2 quarters
Cautiously Optimistic
multi-year
Management's bullish narrative (23% revenue growth, 29% EBITDA growth) is fundamentally contradicted by delivered result showing -87.7% YoY revenue and -86.9% PAT decline. While absolute numbers (₹37.1 Cr rev, ₹16.6 Cr PAT) match the call, the YoY direction reverses management's claims entirely. The core issue: Lab-grown diamond dependence (70%+ of revenue growth) lacks pricing power; natural diamonds (strategic priority) are stalling; AGL is post-acquisition accretive but unproven. Massive QoQ seasonality (-89.9%) masks underlying trend opacity.
₹37.1 Cr
Revenue · −87.7% YoY₹16.6 Cr
Reported PAT · −86.9% YoYFlat
Margins · vs guidance: ContradictedDid the claims hold up?
Q1 revenue growth at 23% YoY
MISSDelivered result shows -87.7% YoY decline. Absolute numbers (₹37.1 Cr) match call, but YoY direction is opposite. Critical discrepancy suggests data anomaly or period mismatch.
EBITDA growth 29% YoY
UnverifiedReported EBITDA 22.38 Cr; PAT decline -86.9% YoY suggests EBITDA growth claim refers to different comparison period or includes non-recurring items.
Started FY27 on strong note with broad-based momentum
OVERSTATEDQ1 revenues down -89.9% QoQ (from implied ₹367 Cr Q4 FY26), indicating massive seasonality or Q4 was an outlier; underlying trend opaque.
Natural diamonds growing 6% ND Loose, 2% ND Jewelry YoY
METAdmitted ND growth underperforming; strategically mining LGD (25–44% growth) to offset ND weakness. Suggests market share losses in natural diamonds despite bullish framing.
AGL acquisition contributing incremental 3% revenue, 2% EBITDA growth
METConsolidated +23% revenue; base business +20%, AGL +3%. Numbers internally consistent. However, AGL adds margin accretion (gemstones >200% growth) but base ND faces pricing & volume headwinds.
Earnings quality
What changed since the last call
Natural diamonds strategic priority downgraded (execution-wise)
DowngradePrior call: 'natural diamonds remain strategic priority' with market share gains via new customer wins. Q1: ND Loose grew 6%, ND Jewelry 2% YoY vs LGD 25-44%. Market share thesis failing; focus has implicitly shifted to LGD volume upside, which carries margin pressure.
AGL acquisition rationale narrowed to TAM expansion
NeutralJustification shifted from 'scaled global player' narrative to focused color-stone expansion in US-led markets (Colombia, Tanzania sourcing). Near-term accretion 3% revenue, 2% EBITDA; long-term unproven.
FY27 guidance re-confirmed at 15% revenue, 20% EBITDA growth
NeutralNo upgrade despite Q1 outperformance claim (23% revenue). CFO held guidance flat 'early days, first quarter.' Suggests guidance conservative or Q1 was seasonal outlier (evidenced by -89.9% QoQ decline).
Margin guidance for India narrowed to 70% range
DowngradePrior: sustained 70%+ margins expected. Q1 actual: 68.8% standalone (down from prior year). Discretionary brand spend (IPL ₹5 Cr) & headcount investments now expected to persist; 70% is aspirational, not baseline.
The Q&A
Analysts pressed hard on (a) pricing power under grower capacity expansion (Harish Advani, Shrenik Mehta), (b) customer concentration (Yog Rajani, Shrenik Mehta), (c) commission payouts to subsidiaries masking India margins (Shrenik Mehta), (d) FY27 guidance conservatism given Q1 beat (Aliasgar Shakir). Management largely deflected: emphasised volume-over-price model, 'negotiation is never-ending' but pricing 'settled' at ₹80-120/carat for 2 years. Eashwar Iyer repeatedly cited 'one IGI model' (India manufacturing + global retail) to justify consolidated EBITDA focus over standalone India margins. Pushback was competent; management dodged some specificity on grower ROCE (10-12% range cited) vs underlying capex needs. Overall: analytical rigor present, but management held the line without major concessions.
LGD pricing power under capacity expansion — Harish Advani, Axis Capital
DodgedConsumer demand expanding fast due to affordability. Certification is central to LGD (otherwise 'piece of glass'). We certify large quantities at scale, consumer confidence is the value. Price is secondary to volume growth.
AGL strategic rationale & geographic expansion — Harit Kapoor, Investec
PartialAGL is leader in US color-stone certification. We're expanding AGL globally: Jaipur collection window, mobile labs to Colombia, Tanzania, other gemstone sourcing regions. AGL gets global platform; IGI gets color-stone expertise & TAM expansion.
ND Loose international growth acceleration — Harit Kapoor, Investec
AnsweredND is key strategic pillar. India has highest market share; globally growing fast. LGD certification is exposing new consumers to IGI; they later upgrade to natural diamonds, already aware of IGI. Expected uptick in natural diamond consumption.
Guidance composition (base business vs AGL) — Harit Kapoor, Investec
Answered15% guidance is on base business. AGL expected to add 2pp on top, so total could be 17%+.
Commission payout to subsidiaries (India margin distortion) — Harit Kapoor, Investec; Shrenik Mehta, IndoAlps Wealth
DodgedIndia manufacturing margin 70-74% over time; can't isolate because interdependencies exist. Retailers in other geographies depend on India manufacturing; commissions are cost of acquiring those leads. One IGI model is the strength. Look at consolidated EBITDA, not standalone in isolation.
Marketing spend quantification (IPL sponsorship front-loaded) — Pallavi, Sameeksha
AnsweredJust under ₹5 Cr spent in Q1 for IPL sponsorship (Gujarat Titans promotion) + brand investments. Headcount increased due to expanded certifications, AI/ML investments, shortened turnaround time requirements. Long-term investment for IGI brand credibility.
EBITDA margin guidance & consolidated vs standalone — Shravan Vohra, Morgan Stanley
AnsweredIndia 70% is correct. Consolidated is 60-64% due to AGL integration and commission payouts. With 15% revenue growth and operating leverage, EBITDA should grow faster than revenue. 100bp margin improvement expected by end of FY27.
ASP improvement drivers: mix vs pricing — Aliasgar Shakir, Motilal Oswal; Shravan Vohra, Morgan Stanley
AnsweredOut of 5% ASP improvement, 3% is AGL, 2% is base business. Mix is the driver: LGD shipments higher caratage than natural diamonds (LGD >1-2 carats vs ND <1 carat pointers). Underlying per-carat pricing stable ₹80-120 for 2 years; not expected to move materially.
LGD customer concentration & negotiating power — Yog Rajani, Omega Portfolio Advisors
PartialTop 8-10 LGD growers produce 80% of India's lab-grown stones, contribute 40-50% of IGI revenues. But they are all dependent on IGI certification (otherwise LGD is 'piece of glass'). Pricing negotiation is ongoing but settled around ₹80-120 range. Capacity doubling expected; we expect to ride volume growth.
AI/ML implementation and revenue vs operational efficiency — Nitin Jain, Fair Value Equity Advisors
AnsweredAI/ML leveraged for operational efficiency: decrease processing time, shorten TAT (2-3 days target). Shorter turnaround translates to better customer experience → better realization & volume. It's cyclical but primarily efficiency-focused.
Revenue CAGR vs Volume CAGR gap (6-7%) — Nitin Jain, Fair Value Equity Advisors
AnsweredGap dates to April-May 2024 pricing correction on LGD (25% price drop). Post-correction (Q1-Q2 FY25), revenue grew 10% but volumes 20%. Since then (last 4-5 quarters), pricing flat and revenue growth mirrors volume growth; no gap.
Guidance
FY27 revenue growth 15% (base business, excl. AGL ~2pp)
LowGuided at 15% FY27 growth. Q1 showed +23% (call) vs -87.7% (delivered result) contradiction. If delivered YoY is correct, guidance 15% is optimistic. If call YoY is correct, delivered result data is anomalous. Either way, guidance credibility weakened.
India standalone EBITDA margin to stabilize in 70% range
LowQ1 actual: 68.8%. Decline from prior year despite +22% revenue growth, due to IPL spend (₹5 Cr front-loaded) & headcount investments. Management expects discretionary spends to moderate; 70% is aspirational. Consolidated margins expected +100bp by YE FY27 via operating leverage.
Incremental capex for volume and business scale-up
LowNo quantum disclosed. Finance cost rising due to 'increased rental payouts on additional office spaces.' Suggests real estate expansion ongoing. No major capex (equipment, lab capacity) guidance provided; implies internally-funded, modest scale.
Risks the call surfaced
Revenue YoY credibility gap
HighManagement claimed +23% YoY revenue growth on call; delivered result shows -87.7% YoY decline. While absolute Q1 revenue ₹37.1 Cr matches, YoY comparison direction is completely opposite. Suggests either data anomaly, restatement, or period mismatch.
LGD customer concentration
High8-10 large LGD growers contribute 40-50% of IGI revenues and produce 80% of India's lab-grown diamonds. Grower ROCE at 10-12% (below cost of capital) may trigger price-cutting demands. Certification is 'critical' but fungible if alternative certification emerges or growers integrate backward.
Natural diamonds strategic priority execution risk
HighND Loose stones +6% YoY, ND Jewelry +2% YoY, both underperforming LGD (25-44%). Management stated ND is 'key strategic pillar' but growth is stalling. Implies market share losses to competitors (GIA, other certifiers) or price concessions IGI has ceded to retain volumes.
Extreme QoQ seasonality
HighQoQ revenue -89.9% (Q1 ₹37.1 Cr vs Q4 ~₹367 Cr implied). Extreme seasonality or Q4 outlier (year-end rush, one-time deals, or 'pull-forward') masks underlying demand trend. FY27 guidance 15% growth anchored to possibly inflated Q4 FY26 base.
AGL integration & TAM expansion unproven
MediumAGL acquired earlier in FY27; now contributing +3% Q1 revenue, +2% EBITDA. Colored gemstone TAM expansion (Jaipur collection window, Colombia/Tanzania sourcing) is strategic but lacks revenue/profitability track record. US-only operation now global; execution risk high.
Pricing power erosion amid capacity doubling
MediumLGD grower capacity expected to double over 3 years. Current wholesale pricing stable ₹80-120/carat for 2 years. If supply gluts materialize faster, certification pricing may face pressure. IGI's volume-dependent model provides limited cushion.
Management
Score 4/10. Moderate clarity. Management deflected on standalone India margin dynamics (comm payouts), grower ROCE negotiation risk. Did not reconcile YoY growth discrepancy. Transparency mixed: shared pricing ranges (₹80-120/carat, 10-12% grower ROCE) but withheld segment breakdowns (carats graded by category) citing competitive sensitivity. Mixed track record. Hit Q1 volume targets (+17% YoY, 3.56 mn reports). LGD revenue growth strong (+25-44%). However, natural diamonds underperformed strategy (+6%, +2% YoY) despite stated priority. AGL integration in early stages; no revenue proof yet. FY26 guidance (prior calls) undisclosed; Q1 FY27 guidance (15% revenue, 20% EBITDA) unproven.
1 · Q2 FY27 (Jul-Sep 2026)
Natural diamond uptick in Diwali quarter; LGD jewelry penetration in India market. Confirm trend reversal post-Q1 collapse.
2 · H2 FY27
AGL color-stone expansion into Jaipur collection window & new geographies (Colombia, Tanzania sourcing centers). Test TAM expansion thesis.
3 · 9-12 months
LGD grower capacity doubling over 3 years (as stated on call). Monitor if pricing erosion accelerates with supply glut.
Massive QoQ seasonality (-89.9%) masks underlying trend opacity.